CLEVELAND - s4story -- Excelas, a trusted provider of medical-legal analysis for more than 20 years, announced that Chase Zaputil has assumed ownership of the company. The transition marks a new chapter grounded in continuity, operational stability and an ongoing commitment to the high standards clients expect.

Under Zaputil's ownership, Excelas will continue delivering the same expert-driven medical-legal analysis that has defined the firm for two decades. The company's core strengths of deep clinical insight, rigorous review processes and a client-first approach remain firmly in place. Clients can expect uninterrupted service, consistent quality and the same experienced team supporting their work.

"Excelas has built a strong reputation by doing the fundamentals exceptionally well," Zaputil said. "Our clients rely on accuracy, clarity and sound judgment, and that does not change. We will continue to invest thoughtfully to support our team and enhance the value we deliver."

More on S For Story

• Michael Roberts Announces the release of Ink Magic: Legacy of the Flower
• Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
• Gyanendra Rana Releases New Self-Help Book - A Monkey Became a Monk
• Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
• 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies

Jean Bourgeois, who founded and led Excelas' operations as its president, emphasized the importance of continuity throughout the transition. "This change in ownership is about strengthening what already works," Bourgeois said. "Chase brings a deep understanding of healthcare, technology and disciplined execution, while fully respecting the expertise, relationships and culture that have made Excelas successful. Our clients should feel confident that Excelas remains steady, focused and committed to excellence."

With its leadership team, staff and service model intact, and Jean staying on in an advisory position, Excelas enters this next phase from a position of strength. The company remains dedicated to providing reliable, expert-led medical-legal analysis with integrity, consistency and a forward-looking mindset for years to come.

Learn more at https://excelas1.com